These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15479670)

  • 1. NOD2 mutations and Crohn's disease: are Paneth cells and their antimicrobial peptides the link?
    Grimm MC; Pavli P
    Gut; 2004 Nov; 53(11):1558-60. PubMed ID: 15479670
    [No Abstract]   [Full Text] [Related]  

  • 2. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
    Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
    Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOD2 mutation and mice: no Crohn's disease but many lessons to learn.
    Wehkamp J; Stange EF
    Trends Mol Med; 2005 Jul; 11(7):307-9. PubMed ID: 15955743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense.
    Wehkamp J; Stange EF
    Ann N Y Acad Sci; 2006 Aug; 1072():321-31. PubMed ID: 17057212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paneth cells: leukocyte-like mediators of innate immunity in the intestine.
    Keshav S
    J Leukoc Biol; 2006 Sep; 80(3):500-8. PubMed ID: 16793911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CARD15/NOD2 mutations in Crohn's disease.
    Hugot JP
    Ann N Y Acad Sci; 2006 Aug; 1072():9-18. PubMed ID: 17057186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defensin-immunology in inflammatory bowel disease.
    Wehkamp J; Stange EF; Fellermann K
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
    Peyrin-Biroulet L; Chamaillard M
    J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD2 in Crohn's disease--loss or gain of function mutations?
    Zelinkova Z; Stokkers P; Hommes DW
    Neth J Med; 2005 Sep; 63(8):286-7. PubMed ID: 16186636
    [No Abstract]   [Full Text] [Related]  

  • 11. A Nod toward understanding Crohn's disease.
    Secko D
    CMAJ; 2005 Mar; 172(6):738-9. PubMed ID: 15767604
    [No Abstract]   [Full Text] [Related]  

  • 12. Events at the host-microbial interface of the gastrointestinal tract. V. Paneth cell alpha-defensins in intestinal host defense.
    Bevins CL
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G173-6. PubMed ID: 16014978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage.
    Tan G; Zeng B; Zhi FC
    Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can NOD2/CARD15 mutations predict intestinal graft-versus-host disease and aid our understanding of Crohn's disease?
    Rogler G; Holler E
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):62-3. PubMed ID: 16265048
    [No Abstract]   [Full Text] [Related]  

  • 15. Paneth cells: their role in innate immunity and inflammatory disease.
    Elphick DA; Mahida YR
    Gut; 2005 Dec; 54(12):1802-9. PubMed ID: 16284290
    [No Abstract]   [Full Text] [Related]  

  • 16. Signalling pathways and molecular interactions of NOD1 and NOD2.
    Strober W; Murray PJ; Kitani A; Watanabe T
    Nat Rev Immunol; 2006 Jan; 6(1):9-20. PubMed ID: 16493424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
    van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
    Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
    Halfvarson J; Bresso F; D'Amato M; Järnerot G; Pettersson S; Tysk C
    Dig Liver Dis; 2005 Oct; 37(10):768-72. PubMed ID: 16002353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crohn's disease is caused by mutations in the bacterial response protein NOD2.
    Press RD
    Mol Diagn; 2001 Dec; 6(4):347-8. PubMed ID: 11837220
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of NOD2 gene in Crohn's disease].
    Hugot JP
    Gastroenterol Clin Biol; 2002 Jan; 26(1):13-5. PubMed ID: 11938034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.